Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (483) Arrow Down
Filter Results: (483) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (483)
    • People  (2)
    • News  (79)
    • Research  (321)
  • Faculty Publications  (186)

Show Results For

  • All HBS Web  (483)
    • People  (2)
    • News  (79)
    • Research  (321)
  • Faculty Publications  (186)
← Page 9 of 483 Results →
  • June 2004 (Revised June 2006)
  • Supplement

Vertex Pharmaceuticals: R&D Portfolio Management (A)

By: Gary P. Pisano, Lee Fleming and Eli Strick
Vertex Pharmaceuticals, Inc., a drug discovery company that recently decided to pursue a vertically integrated business model, chose to build up its clinical development and commercial capabilities and infrastructure. For the first time in its history, Vertex will... View Details
Keywords: Research and Development; Investment Portfolio; Pharmaceutical Industry
Citation
Purchase
Related
Pisano, Gary P., Lee Fleming, and Eli Strick. "Vertex Pharmaceuticals: R&D Portfolio Management (A)." Harvard Business School Supplement 604-101, June 2004. (Revised June 2006.)

    Regina E. Herzlinger

    Regina E. Herzlinger is the Nancy R. McPherson Professor of Business Administration at the Harvard Business School. She was the first woman to be tenured and chaired at Harvard Business School and serve on many established and start-up corporate health care/medical... View Details

    Keywords: health care; insurance industry; medical devices; retailing; digital health
    • April 2019 (Revised January 2025)
    • Case

    Clear Link Technologies, LLC: Driving Sales with Peer Effects

    By: Christopher Stanton, Richard Saouma and Olivia Hull
    The importance of a good peer or coworker is widely discussed, but understanding the glue that makes coworkers valuable is less understood. This case sheds light on the importance of peers and the practices and environments that make a group greater than the sum of its... View Details
    Keywords: Talent and Talent Management; Interactive Communication; Experience and Expertise; Decision Making; Training; Design; Compensation and Benefits; Knowledge Acquisition; Knowledge Sharing; Human Capital; Working Conditions; Measurement and Metrics; Outcome or Result; Performance; Performance Improvement; Research; Sales; Salesforce Management; Motivation and Incentives; Telecommunications Industry; Utah; United States
    Citation
    Educators
    Purchase
    Related
    Stanton, Christopher, Richard Saouma, and Olivia Hull. "Clear Link Technologies, LLC: Driving Sales with Peer Effects." Harvard Business School Case 819-072, April 2019. (Revised January 2025.)
    • March 2010 (Revised May 2012)
    • Case

    Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration

    By: Karim R. Lakhani and Paul R. Carlile
    This case presents the Myelin Repair Foundation's accelerated research collaboration model for drug discovery. It highlights the challenges of building a multi-disciplinary and multi-institutional research collaboration that is attempting to create a treatment for... View Details
    Keywords: Research and Development; Intellectual Property; Risk and Uncertainty; Strategic Planning; Collaborative Innovation and Invention; Health Disorders; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry
    Citation
    Educators
    Purchase
    Related
    Lakhani, Karim R., and Paul R. Carlile. "Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration." Harvard Business School Case 610-074, March 2010. (Revised May 2012.)
    • April 2009
    • Case

    GSK's Acquisition of Sirtris: Independence or Integration?

    By: Toby E. Stuart and James Weber
    An executive from pharmaceutical company GSK must choose how much to integrate a recently acquired biotechnology firm, Sirtris. Moncef Slaoui, GSK's global head of R&D, championed the acquisition of Sirtris to gain access to its potentially revolutionary science.... View Details
    Keywords: Mergers and Acquisitions; Resource Allocation; Organizational Change and Adaptation; Organizational Culture; Organizational Structure; Research and Development; Science-Based Business; Integration
    Citation
    Educators
    Purchase
    Related
    Stuart, Toby E., and James Weber. "GSK's Acquisition of Sirtris: Independence or Integration?" Harvard Business School Case 809-026, April 2009.
    • 10 Aug 2020
    • Research & Ideas

    COVID's Surprising Toll on Careers of Women Scientists

    COVID-19 is claiming an unexpected career toll among scientific researchers, and particularly on women, new research shows. If you are female, have young children, or work in a lab, you are more likely to feel the career-crunching effects... View Details
    Keywords: by Rachel Layne; Pharmaceutical; Pharmaceutical; Pharmaceutical
    • December 2002
    • Article

    Knowledge Seeking and Location Choice of Foreign Direct Investment in the United States

    By: Juan Alcacer and Wilbur Chung
    To what extent do firms go abroad to access technology available in other locations? This paper examines whether and when state technical capabilities attract foreign investment in manufacturing from 1987-1993. We find that on average state R&D intensity does not... View Details
    Keywords: Knowledge Acquisition; Foreign Direct Investment; Research and Development; Information Technology; Production; Geographic Location; United States
    Citation
    Find at Harvard
    Read Now
    Related
    Alcacer, Juan, and Wilbur Chung. "Knowledge Seeking and Location Choice of Foreign Direct Investment in the United States." Management Science 48, no. 12 (December 2002): 1534–1554.
    • 11 Sep 2007
    • First Look

    First Look: September 11, 2007

    Limited was facing significant pricing pressure in their cash cow business, that primarily consisted of manufacturing Active Pharmaceutical Ingredients (APIs). To combat this commoditization, Biocon's leadership had chosen an... View Details
    Keywords: Martha Lagace
    • October 2012
    • Case

    GSK's Acquisition of Sirtris: Independence or Integration? (Abridged)

    By: Toby Stuart and James Weber
    An executive from pharmaceutical company GSK must choose how much to integrate a recently acquired biotechnology firm, Sirtris. Moncef Slaoui, GSK's global head of R&D, championed the acquisition of Sirtris to gain access to its potentially revolutionary science.... View Details
    Keywords: Mergers and Acquisitions; Resource Allocation; Organizational Change and Adaptation; Organizational Culture; Organizational Structure; Research and Development; Science-Based Business; Integration
    Citation
    Educators
    Purchase
    Related
    Stuart, Toby, and James Weber. "GSK's Acquisition of Sirtris: Independence or Integration? (Abridged)." Harvard Business School Case 813-028, October 2012.
    • November 2006 (Revised May 2025)
    • Case

    Eli Lilly: Developing Cymbalta

    By: Elie Ofek and Ron Laufer
    Anticipating the expiration of its Prozac patent, Eli Lilly has to make tough decisions regarding the development of its next-generation antidepressant drug. In particular, the company needs to decide whether to first establish that once-a-day dosing for Cymbalta... View Details
    Keywords: Decision Choices and Conditions; Marketing Strategy; Product Launch; Product Development; Research and Development; Pharmaceutical Industry
    Citation
    Educators
    Purchase
    Related
    Ofek, Elie, and Ron Laufer. "Eli Lilly: Developing Cymbalta." Harvard Business School Case 507-044, November 2006. (Revised May 2025.)
    • Web

    Strategy - Doctoral

    Strategy The doctoral program in Strategy encourages students to pursue multi-disciplinary research that utilizes multiple methodologies—quantitative, as well as qualitative—to study how companies and industries around the world develop... View Details

      Elon Kohlberg

      Elon Kohlberg is the Royal Little Professor of Business Administration at the Harvard Business School. His research is mainly in Game Theory, in particular the study of non-cooperative equilibrium.

      Professor Kohlberg has taught many courses in the MBA,... View Details

      Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
      • 12 Dec 2022
      • Research & Ideas

      Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them

      Black patients and their doctors may be more open to new medications if drug trials included more Black people, new research shows. Currently, Black Americans represent just 5 percent of drug trial participants. Nearly three-quarters of... View Details
      Keywords: by Scott Van Voorhis; Pharmaceutical; Pharmaceutical
      • 11 Aug 2003
      • Research & Ideas

      Cheap, Fast, and In Control: How Tech Aids Innovation

      experimentation and are triggering fundamental changes in R&D processes and performance in such fields as integrated circuit design, automotive development, and pharmaceutical drug discovery. Computer modeling and simulation, rapid... View Details
      Keywords: by Wendy Guild
      • 28 Jul 2008
      • Research & Ideas

      Making the Decision to Franchise (or not)

      of store-level employees. "Franchising is a very observable, real choice that organizations make," says Campbell. It's also an extreme solution to the challenge of operating across multiple markets; future research will focus on other,... View Details
      Keywords: by Julia Hanna; Retail
      • December 1999
      • Case

      Agrochemicals at Ciba-Geigy AG (A)

      By: Michael L. Tushman, Wendy Smith and Daniel Radov
      After spending five years to develop a revolutionary product, the director of Ciba-Geigy's fungicide research department is handed an unfavorable market study. The case details the R&D process for the new product, including information on corporate partnerships,... View Details
      Keywords: Agribusiness; Plant-Based Agribusiness; Research and Development; Innovation and Invention; Innovation Strategy; Product Launch; Marketing Channels; Change Management; Product Development; Business Processes; Organizational Structure; Corporate Accountability; Pharmaceutical Industry; Pharmaceutical Industry
      Citation
      Find at Harvard
      Related
      Tushman, Michael L., Wendy Smith, and Daniel Radov. "Agrochemicals at Ciba-Geigy AG (A)." Harvard Business School Case 400-022, December 1999.
      • June 2003 (Revised March 2008)
      • Case

      Schering-Plough and Genome Therapeutics: Discovering an Asthma Gene

      By: Regina E. Herzlinger and Marc Aquino
      Personalized medicine requires the identification of mutated genes. Schering-Plough's search for the one related to asthma requires finding families with the disease. Examines the industry that helps conduct such research, including contract research organizations. View Details
      Keywords: Health Disorders; Research and Development; Genetics; Pharmaceutical Industry; Pharmaceutical Industry
      Citation
      Educators
      Purchase
      Related
      Herzlinger, Regina E., and Marc Aquino. "Schering-Plough and Genome Therapeutics: Discovering an Asthma Gene." Harvard Business School Case 303-044, June 2003. (Revised March 2008.)
      • Forthcoming
      • Article

      Achieving Epilepsy Care for All: Ecosystem-Based Transformation

      By: Susanna Gallani, Bernice Martin Lee and Lidia M. V. R. Moura
      Epilepsy exemplifies many of the systemic challenges of modern health care— fragmented care delivery, inequitable access, financial strain, and so on. The current “system of systems” (SoS) structure of U.S. health care fosters siloed operations among its member systems... View Details
      Keywords: Healthcare Delivery; Epilepsy; Seizures; Health Care and Treatment; Health Disorders; Equality and Inequality; Framework; Service Delivery
      Citation
      Find at Harvard
      Read Now
      Purchase
      Related
      Gallani, Susanna, Bernice Martin Lee, and Lidia M. V. R. Moura. "Achieving Epilepsy Care for All: Ecosystem-Based Transformation." Epilepsia (forthcoming). (Pre-published online April 4, 2025.)
      • 15 Jan 2008
      • First Look

      First Look: January 15, 2008

      explore the role of assumptions underlying knowledge creation within the field of organizational studies, and investigate how incompatible assumptions across subgroups may inhibit the generation of multidisciplinary knowledge. While organizational studies View Details
      Keywords: Martha Lagace
      • 21 Apr 2009
      • First Look

      First Look: April 21, 2009

      participation decisions. Based on our experimental results, we suggest preliminary lessons for improving the design of household risk management contracts. Download the paper: http://www.hbs.edu/research/pdf/09-116.pdf Where Is the Pharmacy to the World? International... View Details
      Keywords: Martha Lagace
      • ←
      • 9
      • 10
      • …
      • 24
      • 25
      • →
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Accessibility
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College.